Long-Term Follow-up of AML Patients Treated Intensively before the Era of Targeted Agents. a Big Data Analysis from the Harmony Collaboration
Marta Sobas, Lars Bullinger(Stanford University), María Abáigar(Universidad de Salamanca), Laura Tur(GMV Innovating Solutions (Spain)), Alberto Hernández‐Sánchez, Eric Sträng(Humboldt-Universität zu Berlin), Jorge Sierra(Universitat Autònoma de Barcelona), Klaus H. Metzeler(University Hospital Leipzig), Javier Martínez Elicegui(Instituto de Investigación Biomédica de Salamanca), Axel Benner(Memorial Sloan Kettering Cancer Center), Castellani Gastone(Istituto Nazionale di Fisica Nucleare, Sezione di Bologna), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Jesús María Hernández‐Rivas(Universidad de Salamanca), Daniele Dall’Olio(University of Bologna), Torsten Haferlach(Martin Luther Christian University), Jesse M. Tettero(Amsterdam Neuroscience), Renate Schulze‐Rath(Sanofi (France)), Konstanze Döhner(University Hospital Ulm), Amin T. Turki(University Hospitals of the Ruhr-University of Bochum), Rubén Villoria Medina(GMV Innovating Solutions (Spain)), Raúl Azibeiro Melchor(Universidad de Salamanca), Sören Lehmann(Uppsala University), Ángela Villaverde Ramiro(Instituto de Investigación Biomédica de Salamanca), Ken Mills(Johns Hopkins University), Dirk Reinhardt(Society of Paediatric Oncology and Haematology), Rosa Ayala(Hospital Universitario 12 De Octubre), Hartmut Döhner(University Hospital Ulm), Matteo Giovanni Della Porta(Humanitas University), Teresa González(Instituto de Investigación Biomédica de Salamanca), Frederick Damm(Charité - Universitätsmedizin Berlin), Brian James Patrick Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Gert J. Ossenkoppele(Dutch Cancer Society), Martje Barbus(AbbVie (Germany)), Jiří Mayer(Central European Institute of Technology), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k